Elanco Animal Health Incorporated
Health
Performance
5.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

Elanco Animal Health Incorporated stock rating and score history

All changes in ratings, performance and outlook tracked over time.

25.12.2025
Signs of control returning. Still shaky, but not chaos.
13.12.2025
Shaky at first, now slowly moving toward steady ground.
16.09.2025
Short-term strength kicking in. Early signs of life.
24.08.2025
Health turning shaky. Something under the hood’s off.

Elanco Animal Health Incorporated stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Elanco Animal Health Incorporated do? Business model and key facts

Get the full picture of Elanco Animal Health Incorporated: what it builds, where it operates, and how it makes money.

Elanco Animal Health Incorporated Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 9000

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

shop
Company facts
Jeffrey N. Simmons
CEO
9000
Employees worldwide
shop
Performance
104.64%
Last 12 months
-18.68%
Last 5 years
shop
Growth
$4,44B
Revenue year
$338,00M
Net income
shop
Valuation
$12,26B
Market Cap
17.70
Price/Earnings Ratio

Stocks related to Elanco Animal Health Incorporated

Selected based on industry alignment and relative market positioning.

NBIX
Neurocrine Biosciences, Inc.
134.60
+0.07%
4.1
Sell
Buy
Neurocrine Biosciences, Inc.
VTRS
Viatris Inc.
13.24
+0.53%
4.2
Sell
Buy
Viatris Inc.
TEVA
Teva Pharmaceutical Industries Limited
31.90
-0.76%
5.4
Sell
Buy
Teva Pharmaceutical Industries Limited
RDY
Dr. Reddy's Laboratories Limited
13.70
-0.62%
2.5
Sell
Buy
Dr. Reddy's Laboratories Limited
LNTH
Lantheus Holdings, Inc.
67.53
-0.42%
7.1
Sell
Buy
Lantheus Holdings, Inc.

Elanco Animal Health Incorporated fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.